-
Publication Venue For
-
Conversations With the Editors: Promoting Science and Combating Anti-science: The Past and Present of the Antivaccine Movement..
42:2248-2252.
2020
-
The Enhancing Quality of Prescribing Practices for Older Veterans Discharged From the Emergency Department (EQUIPPED) Potentially Inappropriate Medication Dashboard: A Suitable Alternative to the In-person Academic Detailing and Standardized Feedback Reports of Traditional EQUIPPED?.
42:573-582.
2020
-
Innovations in HIV-1 Vaccine Design..
42:499-514.
2020
-
Host-Based Diagnostics for Acute Respiratory Infections..
41:1923-1938.
2019
-
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies..
41:1090-1096.
2019
-
Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry..
40:1193-1202.e1.
2018
-
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis..
40:156-165.e5.
2018
-
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens..
39:1706-1718.
2017
-
Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?.
39:659-660.
2017
-
Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric Approval..
38:1995-2005.
2016
-
Principles of Anti-infective Dosing in Pregnancy..
38:2006-2015.
2016
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus..
38:1417-1434.e2.
2016
-
The Alarmin Properties of DNA and DNA-associated Nuclear Proteins..
38:1029-1041.
2016
-
Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment..
38:531-544.
2016
-
Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors..
37:1975-1985.
2015
-
Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications..
37:1924-1932.
2015
-
Understanding the Complexities of Cirrhosis..
37:1822-1836.
2015
-
Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists..
37:1477-1482.e1.
2015
-
Development and initial assessment of the medication user self-evaluation (MUSE) tool..
35:344-350.
2013
-
Emergent anxiety after antidepressant initiation: a retrospective cohort study of Veterans Affairs Health System patients with depression..
33:1985-1992.e1.
2011
-
A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005..
32:1308-1319.
2010
-
Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover study..
31:1716-1723.
2009
-
Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank..
31:1871-1880.
2009